Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Goldberg

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Cancer|October 24, 2000
A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinomaH C Pitot, J A Knost, M R Mahoney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancerC L Loprinzi, S A Kuross, J R O'Fallon, et al.
Cancer|September 15, 1995
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo ClinicR M Goldberg, C G Moertel, H S Wieand, et al.
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
British Journal of Cancer|November 3, 2005
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerS P Ackland, M Jones, D Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaC L Loprinzi, J C Michalak, D J Schaid, et al.
Cancer|April 1, 1996
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinomaJ T Schleusener, H D Tazelaar, S H Jung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.
Annals of Surgical Oncology|April 18, 2008
Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancerA S Caudle, H J Kim, J E Tepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566C Erlichman, A A Adjei, S R Alberts, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Cancer|October 24, 2000
A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinomaH C Pitot, J A Knost, M R Mahoney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancerC L Loprinzi, S A Kuross, J R O'Fallon, et al.
Cancer|September 15, 1995
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo ClinicR M Goldberg, C G Moertel, H S Wieand, et al.
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
British Journal of Cancer|November 3, 2005
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerS P Ackland, M Jones, D Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaC L Loprinzi, J C Michalak, D J Schaid, et al.
Cancer|April 1, 1996
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinomaJ T Schleusener, H D Tazelaar, S H Jung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.
Annals of Surgical Oncology|April 18, 2008
Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancerA S Caudle, H J Kim, J E Tepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566C Erlichman, A A Adjei, S R Alberts, et al.
Pageof 9